Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06671769 · ClinicalTrials.gov registry record · Phase 1
Natural Heart Health Supplement Trial
A Phase 1 study, sponsored by Efforia.
- Not yet
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
NCT06671769: Clinical Trial Phase 1 study, sponsored by Efforia.
NCT06671769 is a Phase 1 study that has not yet begun recruiting, run by Efforia. The registered enrollment target is 60 participants, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06671769, a Phase 1 study, has not yet begun recruiting, sponsored by Efforia.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
Study Summary
We are running a 3-month trial of an experimental natural heart health supplement. Participants will take a daily dose of an experimental natural heart health supplement in powdered format, chocolate flavor. The trial will assess changes in heart biomarkers such as Total Cholesterol, HDL-C, LDL-C, Triglycerides, and High-Sensitivity C-reactive protein (hs-CRP).
Primary Outcome
Total Cholesterol as measured by an at-home blood collection kit returned to the lab
Interventions
- DIETARY_SUPPLEMENT Heart Health Supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-01-15 |
| Est. Completion | 2025-05-01 |
| Phase | Phase 1 |
What is known before NCT06671769 opens enrollment
NCT06671769 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target.
The record links to 0 conditions, and to 1 intervention - of which Heart Health Supplement is the first listed.
NCT06671769 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06671769 about?
NCT06671769 is a clinical study titled "Natural Heart Health Supplement Trial". We are running a 3-month trial of an experimental natural heart health supplement. Participants will take a daily dose of an experimental natural heart health supplement in powdered format, chocolate flavor. The trial will assess changes in heart biomarkers such as Total Cholesterol, HDL-C, LDL-C, T...
What is the current status of trial NCT06671769?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2025-01-15. Estimated completion is 2025-05-01.
What interventions are being tested in trial NCT06671769?
The interventions under investigation include: Heart Health Supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06671769?
This trial is sponsored by Efforia, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06671769's enrollment target sits among peer trials
60 831st of 2000 higher than 1,106 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI